Description
A PARP1 inhibitor (Ki = 6.3 nM); inhibits PARP1 activity in permeabilized and intact SW620 cells (IC50s = 29 and 14 nM, respectively); potentiates the growth inhibitory effects of temozolomide and topotecan in vitro at 0.4 µM; also inhibits cell growth in a PARP1-independent manner (GI50s = 66 and 65 µM for cells derived from PARP1+/+ and PARP1-/- mice, respectively); leads to tumor regression in an SW620 mouse xenograft model when used in combination with temozolomide
Formal name: 2-[4-[(dimethylamino)methyl]phenyl]-5,6-dihydro-imidazo[4,5,1-jk][1,4]benzodiazepin-7(4H)-one
Synonyms:
Molecular weight: 320.4
CAS: 328543-09-5
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|DNA Repair Enzymes||Research Area|Cancer|DNA Damage and Repair|PARP